Keensight Capital, one of the leading private equity managers dedicated to European Growth Buyout investments, has raised €2.8 billion in funds to invest in leading Technology and Healthcare companies.
Keensight Capital’s recent fundraise was significantly oversubscribed, with strong support from existing LPs, as well as new investors from Europe, North America, the Middle East, and Asia. This globally diverse LP base generated c.90% of subscriptions from institutional investors (asset managers, pension funds, insurance companies, banks and sovereign wealth funds), and c.10% from former portfolio company CEOs and family offices.
Keensight Capital will continue to pursue its consistent and successful investment strategy as a leader of European Growth Buyouts.
The Clifford Chance team was composed of Xavier Comaills, partner, as well as Louis-Guillaume Cousin and Patrick Biancaniello, associates.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
